knowledge -WSS

knowledge

author：leisure time 2025-08-23 18:38:08 - browse：69

Feng Zhang Editas — Aera was formed to pursue a nanoparticle described by Feng Zhang in 2021. Susan Walsh/AP

Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company confirmed to STAT.

The layoffs come as the biotech market remains mired in a now nearly three-year-long downturn that has left startups struggling to attract both private and public funds. Aera attributed the layoffs to those headwinds and indicated it had axed a portion of the company dedicated to developing new gene-editing enzymes.

“In 2023, Aera launched to pursue an ambitious mission to develop transformative genetic medicines by harnessing enabling delivery technologies and precision payloads,” spokesman Dan Budwick said in a statement. “Although Aera remains in a strong cash position today, given the current biotech funding environment, we have chosen to take steps to focus our strategy and investments on the development of our novel delivery platforms, thereby further extending our cash runway.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： FDA approves updated Covid vaccines

hotspot

WSS

Will the IRA bring competition to the biologics market?

New details revealed about Purdue's marketing of OxyContin

The pain doctors face in trying to build their families

How housing is health care on Long Island

A common UTI test for kids haunts adults as a traumatic 'nightmare'

An interview with Robert F. Kennedy Jr. on vaccines

focus

knowledge

focus

As demand for Covid shots wanes, Moderna seeks its next success

Long Covid needs a new name — and a new frame

Novavax promises a turnaround & Lilly roils the obesity market

ProMED sees offers of support, but its future remains unclear

Dobbs anniversary: the lost opportunity of abortion as health care

Baltimore teen accused of firing into crowd during block party mass shooting

The high cost of giving birth even with insurance

The pain doctors face in trying to build their families

Virginia high school admissions case could be legal follow

A common UTI test for kids haunts adults as a traumatic 'nightmare'

hotspot

New details revealed about Purdue's marketing of OxyContin

FDA approves updated Covid vaccines

Popular nasal decongestant doesn't actually relieve congestion

Walmart eyes Medicare Advantage provider ChenMed

Trump cancels press conference intended to dispute Georgia election interference charges

Listen: Racing for gene therapy & a pioneering approval

hotspot

hotspot

focus

knowledge